Compare
Arcadia Biosciences, Inc. vs Viking Global Technologies, Inc. vs Trio Petroleum Corp vs Evolution Petroleum Corp
| Latest fiscal year | Arcadia Biosciences, Inc. RKDA | Viking Global Technologies, Inc. VGTK | Trio Petroleum Corp TPET | Evolution Petroleum Corp EPM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-10-31 | 2026-06-30 |
| Revenue | $4.86M | $6.23M | $398.7K | $86.34M |
| Revenue growth (YoY) | -3.7% | -78.2% | +87.0% | +0.6% |
| Gross margin | 36.2% (computed) | 25.4% (computed) | 55.9% | 41.7% (computed) |
| Operating margin | -51.5% | -127.6% | n/m | 4.0% |
| Net margin | -48.1% | -70.8% | n/m | -2.8% |
| Net income | -$2.34M | -$4.41M | -$7.28M | -$2.43M |
| EPS (Diluted) | -$1.71 | -$0.02 | -$0.80 | -$0.08 |
| Operating cash flow | -$4.74M | -$2.33M | -$2.60M | $23.52M |
| Free cash flow | -$4.74M | -$2.34M | n/a | n/a |
| Cash & equivalents | $259.0K | n/a | n/a | $6.14M |
| Total assets | $6.55M | $19.84M | $13.21M | $168.70M |
| Total liabilities | $2.41M | $63.21M | $1.91M | $108.29M |
| Shareholders' equity | $4.14M | -$49.77M | $11.30M | $60.40M |
| Return on year-end equity | -56.5% | n/a | -64.4% | -4.0% |
| Shares outstanding | 1.37M | 281.69M | 9.05M | 35.95M |
Revenue, most recent five fiscal years
| Fiscal year | Arcadia Biosciences, Inc. | Viking Global Technologies, Inc. | Trio Petroleum Corp | Evolution Petroleum Corp |
|---|---|---|---|---|
| Latest | $4.86M Ended 2025-12-31 | $6.23M Ended 2025-12-31 | $398.7K Ended 2025-10-31 | $86.34M Ended 2026-06-30 |
| 1 year earlier | $5.04M Ended 2024-12-31 | $28.61M Ended 2024-12-31 | $213.2K Ended 2024-10-31 | $85.84M Ended 2025-06-30 |
| 2 years earlier | $4.45M Ended 2023-12-31 | $32.05M Ended 2023-12-31 | n/a | $85.88M Ended 2024-06-30 |
| 3 years earlier | $7.42M Ended 2022-12-31 | $24.04M Ended 2022-12-31 | n/a | $128.51M Ended 2023-06-30 |
| 4 years earlier | $6.78M Ended 2021-12-31 | $401.2K Ended 2021-12-31 | n/a | $108.93M Ended 2022-06-30 |